UnitedHealthcareMedicare Advantage · Documentation · Medical Policy · Wound Care, Dermatology, OrthopedicsLow impact
Platelet Rich Plasma Therapies
Effective date
Nov 1, 2026
Identified
Nov 7, 2026
Summary
UnitedHealthcare's Medicare Advantage bulletin for November 2026 updated its Platelet Rich Plasma Therapies medical policy by adding reference links to CMS transmittals and MLN Matters articles tied to NCD 270.3 (Blood-Derived Products for Chronic, Non-Healing Wounds) and to ICD-10 and other coding revisions to National Coverage Determinations, and by refreshing the FDA section and the list of Medicare Coverage Database documents. The changes are reference and documentation updates rather than new coverage criteria stated in the text provided. Billing teams should review the updated policy reference set for wound-related and PRP-related services billed to these Medicare Advantage plans.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.
01Already effective 2026-11-01: Billing team should review the updated Platelet Rich Plasma Therapies policy and its refreshed CMS and FDA references in the MA medical policy library, and share the updated reference list with providers who order or perform PRP-related services.
02Where wound-related PRP services are billed, confirm that charge entry and documentation for those Medicare Advantage claims reflect the coverage framework cited in NCD 270.3 and the coding revisions referenced in the bulletin.
Original notice
Platelet Rich Plasma Therapies
uhcprovider.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.